A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 48/00 (2006.01) A61K 31/70 (2006.01) A61K 33/24 (2006.01) A61K 38/19 (2006.01)
Patent
CA 2209771
A medicinal combination of one or more nucleic acids that at least partially inhibit oncogenic cell signalling pathways, and a therapeutic anticancer agent, for use simultaneous, separate or over a period of time to treat hyperproliferative diseases.
La présente invention concerne une association médicamenteuse d'un ou plusieurs acides nucléiques inhibant au moins partiellement les voies de signalisation cellulaires oncogéniques, et d'un agent thérapeutique anticancéreux, pour une utilisation simultanée, séparée ou étalée dans le temps pour le traitement des pathologies hyperprolifératives.
Aventis Pharma S.a.
Rhone-Poulenc Rorer S.a.
Robic
LandOfFree
Combined therapeutical treatment of hyperproliferative diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combined therapeutical treatment of hyperproliferative diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined therapeutical treatment of hyperproliferative diseases will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1880210